Estrogen sulfotransferase (SULT1E1) regulates inflammatory response and lipid metabolism of human endothelial cells via PPARγ

Molecular and Cellular Endocrinology

Volumn 369, Issue 1-2, 2013, Pages 140-149

  Xu, Yali ^a   Yang, Xiaoming ^a   Wang, Zhengyang ^a   Li, Mengmeng ^a   Ning, Yanxia ^a   Chen, Sifeng ^a   Yin, Lianhua ^a   Li, Xiaobo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Endothelial cells; Estrogen sulfation; Inflammatory factors; PPAR ; SULT1E1

Indexed keywords

APOLIPOPROTEIN B; CD36 ANTIGEN; ESTRADIOL; ESTROGEN SULFOTRANSFERASE; INTERLEUKIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA;

ARTICLE; CATALYSIS; CELL FUNCTION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; INFLAMMATION; LIPID METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; RNA SYNTHESIS; SULFATION;

ENDOTHELIAL CELLS; ESTRADIOL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPID METABOLISM; METABOLIC DETOXICATION, PHASE II; PPAR GAMMA; RNA INTERFERENCE; SULFOTRANSFERASES;

EID: 84875051228     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.01.020     Document Type: Article

References (33)

1. Bai Q., Li X., Ning Y., Zhao F., Yin L. Mitochondrial cholesterol transporter, StAR, inhibits human THP-1 monocyte-derived macrophage apoptosis. Lipids 2010, 45:29-36.
2. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 2003, 23:168-175.
3. Chinetti G., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 2000, 49:497-505.
4. Choi J.Y., Lee K.M., Park S.K., et al. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1090-1095.
5. Cole G.B., Keum G., Liu J., Small G.W., Satyamurthy N., Kepe V., Barrio J.R. Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates. Proc. Natl. Acad. Sci. USA 2010, 107:6222-6227.
6. Coughtrie M.W. Sulfation through the looking glass-recent advances in sulfotransferase research for the curious. Pharmacogenomics J. 2002, 2:297-308.
7. Duanmu Z., Weckle A., Koukouritaki S.B., Hines R.N., Falany J.L., Falany C.N., Kocarek T.A., Runge-Morris M. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J. Pharmacol. Exp. Ther. 2006, 316:1310-1317.
8. Han Y., Qi Y., Kang J., Li N., Tian X., Yan C. Nerve growth factor promotes formation of lumen-like structures in vitro through inducing apoptosis in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2008, 366:685-691.
9. Hirata H., Hinoda Y., Okayama N., Suehiro Y., Kawamoto K., Kikuno N., Rabban J.T., Chen L.M., Dahiya R. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer 2008, 112:1964-1973.
10. Kiely J.M., Luscinskas F.W., Gimbrone M.A. Leukocyte-endothelial monolayer adhesion assay (static conditions). Methods Mol. Biol. 1999, 96:131-136.
11. Kim K.H., Bender J.R. Membrane-initiated actions of estrogen on the endothelium. Mol. Cell. Endocrinol. 2009, 308:3-8.
12. Kushida A., Hattori K., Yamaguchi N., Kobayashi T., Date A., Tamura H. Sulfation of estradiol in human epidermal keratinocyte. Biol. Pharm. Bull. 2011, 34:1147-1151.
13. Li J., Wang N. Peroxisome proliferator-activated receptor-gamma in vascular biology. Cardiovasc. Hematol. Disord.: Drug Targets 2007, 7:109-117.
14. Magri C.J., Gatt N., Xuereb R.G., Fava S. Peroxisome proliferator-activated receptor-gamma and the endothelium: implications in cardiovascular disease. Expert Rev. Cardiovasc. Ther. 2011, 9:1279-1294.
15. Maltais R., Poirier D. Steroid sulfatase inhibitors: a review covering the promising 2000-2010 decade. Steroids 2011, 76:929-948.
16. Meier M., Moller G., Adamski J. Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease. Ann. N. Y. Acad. Sci. 2009, 1155:15-24.
17. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999, 340:1801-1811.
18. Meyer M.R., Haas E., Prossnitz E.R., Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol. Cell. Endocrinol. 2009, 308:9-16.
19. Mukherjee T.K., Nathan L., Dinh H., Reddy S.T., Chaudhuri G. 17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. J. Biol. Chem. 2003, 278:11746-11752.
20. Nakagami F., Nakagami H., Osako M.K., Iwabayashi M., Taniyama Y., Doi T., Shimizu H., Shimamura M., Rakugi H., Morishita R. Estrogen attenuates vascular remodeling in Lp(a) transgenic mice. Atherosclerosis 2010, 211:41-47.
21. Purohit A., Woo L.W., Potter B.V. Steroid sulfatase: a pivotal player in estrogen synthesis and metabolism. Mol. Cell. Endocrinol. 2011, 340:154-160.
22. Russell K.S., Haynes M.P., Sinha D., Clerisme E., Bender J.R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc. Natl. Acad. Sci. USA 2000, 97:5930-5935.
23. Sobrino A., Oviedo P.J., Novella S., Laguna-Fernandez A., Bueno C., Garcia-Perez M.A., Tarin J.J., Cano A., Hermenegildo C. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}. J. Mol. Endocrinol. 2010, 44:237-246.
24. Spandidos A., Wang X., Wang H., Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010, 38:D792-D799.
25. Tong M.H., Jiang H., Liu P., Lawson J.A., Brass L.F., Song W.C. Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase - deficient mice. Nat. Med. 2005, 11:153-159.
26. Wada T., Ihunnah C.A., Gao J., Chai X., Zeng S., Philips B.J., Rubin J.P., Marra K.G., Xie W. Estrogen sulfotransferase inhibits adipocyte differentiation. Mol. Endocrinol. 2011, 25:1612-1623.
27. Wu Q., Chambliss K., Umetani M., Mineo C., Shaul P.W. Non-nuclear estrogen receptor signaling in the endothelium. J. Biol. Chem. 2011, 286:14737-14743.
28. Xu L., Bai Q., Rodriguez-Agudo D., Hylemon P.B., Heuman D.M., Pandak W.M., Ren S. Regulation of hepatocyte lipid metabolism and inflammatory response by 25-hydroxycholesterol and 25-hydroxycholesterol-3-sulfate. Lipids 2010, 45:821-832.
29. Xu L., Shen S., Ma Y., Kim J.K., Rodriguez-Agudo D., Heuman D.M., Hylemon P.B., Pandak W.M., Ren S. 25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARgamma signaling in human THP-1 macrophages. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E788-E799.
30. Xu Y., Liu X., Guo F., Ning Y., Zhi X., Wang X., Chen S., Yin L., Li X. Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers. Cancer Sci. 2012, 103:1000-1009.
31. Yeong P., Ning Y., Xu Y., Li X., Yin L. Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRalpha activation. Biochim. Biophys. Acta 2010, 1801:567-576.
32. Yue T.L., Wang X., Louden C.S., Gupta S., Pillarisetti K., Gu J.L., Hart T.K., Lysko P.G., Feuerstein G.Z. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol. Pharmacol. 1997, 51:951-962.
33. Zhu B.T., Lee A.J. NADPH-dependent metabolism of 17beta-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms. Steroids 2005, 70:225-244.